VK

Vijay Kumar

Active Director Director DIN 08513993
DIN 08513993 First appointment Jul 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value •••• Premium profile

About Vijay Kumar

Data last updated:

Vijay Kumar is a Director at Lizard Pharma Private Limited (since 2019). The company operates in Chemicals. Lizard Pharma Private Limited reported revenue of ₹19.6 Lakh (FY 2021).

DIN 08513993
Primary Designation Director
Industry Chemicals
First Appointment 18 Jul 2019
Oldest Company Age 7 yrs
Largest company Lizard Pharma Private Limited · ₹19.6 Lakh (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lizard Pharma Private Limited U24120UP2019PTC119255
Director18 Jul 20192019₹19.6 Lakh (FY 2021)Active

Board colleagues of Vijay Kumar

NameDINCompanyDesignation
Anoop Kumar Srivastav08513994Lizard Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lizard Pharma Private Limited
Premium access

Shareholding and investment profile for Vijay Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Kumar

Vijay Kumar currently holds 1 directorship: Lizard Pharma Private Limited (Director, since 18 Jul 2019, revenue ₹19.6 Lakh (FY 2021)).

Vijay Kumar was first appointed on 18 Jul 2019 as Director at Lizard Pharma Private Limited.

The current boards of Vijay Kumar's companies include Anoop Kumar Srivastav (Lizard Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available